hospitalization rates, LVEF distribution, left ventricular ejection fraction, epidemiology, HF subtype, EF group, EF phenotypes, reduced ejection fraction, HFrEF, mildly reduced ejection fraction, HFmrEF, preserved ejection fraction, HFpEF, Get with the Guidelines, GWTG-HF registry
Hospitalizations, hospitalization rates, hospitalization volumes, annual hospitalizations, US trends, trends in hospitalizations, epidemiology, HF subtype, EF group, EF phenotypes, hospitalizations by EF group, reduced ejection fraction, HFrEF, preserved ejection fraction, HFpEF, US, United States
Hospitalizations, hospitalization rates, 5-year all-cause readmissions, five-year readmissions, 5-year mortality, incidence curves, long-term outcomes, readmissions by sex, sex differences, males vs females, readmissions by EF group, hospitalizations by EF group, epidemiology, HF subtype, EF group, EF phenotypes, reduced ejection fraction, HFrEF, mildly reduced ejection fraction, HFmrEF, preserved ejection fraction, HFpEF, Get with the Guidelines, GWTG-HF registry
Hospitalizations, hospitalization rates, trends in hospitalizations, US trends, trends according to age, hospitalizations by age, age categories, elderly adults, older adults, 80 years or older, ≥80 years old, US, United States
Hospitalizations, hospitalization rates, trends in hospitalization, US trends, trends according to age, hospitalizations by age, age categories, trends according to sex, hospitalizations by sex, sex differences, males vs females, men, women, trends according to race/ethnicity, hospitalizations by race/ethnicity, race categories, ethnic categories, racial differences, blacks, whites, hispanics, trends according to location, urban vs rural trends, trends by location of hospital, urban vs rural, urban hospital, rural hospital, US, United States
Hospitalizations, hospitalization rates, trends in hospitalization, unique patient visits, post-hospitalization, post-discharge, readmissions, hospital readmissions, hospitalization trends, readmission trends, US trends, trends in the US, hospitalizations per year, 30-day all-cause readmissions, unique patients, comorbid diagnosis, US, United States
death rates, mortality rates, incidence rates, incidence curves, cause of death, LVEF, continuous LVEF, left ventricular ejection fraction, sudden death, cardiovascular deaths, non-cardovascular deaths, EF spectrum, pooled analysis
death rates, mortality rates, 1-year outcomes, one-year outcomes, 1-year mortality, one-year mortality, epidemiology, deaths by EF group, epidemiology, left ventricular ejection fraction, LVEF, HF subtype, EF group, EF phenotypes, reduced ejection fraction, HFrEF, mildly reduced ejection fraction, HFmrEF, preserved ejection fraction, HFpEF, ESC-HF-LT registry, cardiovascular deaths, non-cardiovascular deaths
death rates, 1-year all-cause mortality, all-cause mortality, mortality rates, mortality in registries, mortality in randomized controlled trials, mortality in clinical trials, deaths by registries, deaths by clinical trials, death by EF group, epidemiology, EF spectrum, HF subtype, EF group, EF phenotypes, reduced ejection fraction, HFrEF, mildly reduced ejection fraction, HFmrEF, preserved ejection fraction, HFpEF, ESC-HF-LT registry, SwedeHF registry, GWTG-HF registry, Get with the Guidelines, TIME-CHF registry, CHART-2 registry, TOPCAT trial, TOPCAT Americas, BB-meta-HF trial, DIG trial, CHARM trial, PARADIGM PARAGON trial
death rates, all-cause mortality, mortality rates, adjusted for age and sex, incidence curves, mortality by EF group, death by EF group, epidemiology, HF subtype, EF group, EF phenotypes, reduced ejection fraction, HFrEF, mildly reduced ejection fraction, HFmrEF, preserved ejection fraction, HFpEF, cohort studies, multi-ethnic cohort study, international study, New Zealand, Singapore
